Related Experiment Videos
New carriers and adjuvants in the development of vaccines
1World Health Organization, University of Geneva, Switzerland.
Current Opinion in Immunology
|August 1, 1992
Abstract:
Different approaches are being followed to enhance the immunogenicity of established and newly developed vaccines. Some of them foresee the utilization of carrier molecules recognized by the immune systems of a large proportion of the human population. Others are directed mainly towards the development of improved adjuvants and delivery systems.